Why the study?
Cardiopulmonary exercise testing carries additional cost and competency requirements and is not essential for all patients, but provides valuable data for clinical decision-making in specific conditions of confirmed, suspected, or unknown etiology.
Does cardiopulmonary exercise testing (CPX) with condition-specific data interpretation charts improve diagnostic clarification, prognostic stratification, and clinical decision-making in patients with cardiovascular, pulmonary, and musculoskeletal disorders?
Does cardiopulmonary exercise testing (CPX) with condition-specific data interpretation charts improve diagnostic clarification, prognostic stratification, and clinical decision-making in patients with cardiovascular, pulmonary, and musculoskeletal disorders?
This joint EACPR/AHA position paper establishes a simplified, standardized, condition-specific framework and color-coded stratification charts to make cardiopulmonary exercise testing data easily interpretable for routine clinical decision-making.
Answers are grounded in this paper and cite their sources.
Supports CPX integration for condition-specific stratification in cardiovascular and pulmonary diseases; reinforces consensus on its diagnostic and prognostic value.
From an evidence-based perspective, cardiopulmonary exercise testing (CPX) is a well-supported assessment technique in both the United States (US) and Europe. The combination of standard exercise testing (ET) (ie, progressive exercise provocation in association with serial electrocardiograms [ECG], hemodynamics, oxygen saturation, and subjective symptoms) and measurement of ventilatory gas exchange amounts to a superior method to: 1) accurately quantify cardiorespiratory fitness (CRF), 2) delineate the physiologic system(s) underlying exercise responses, which can be applied as a means to identify the exercise-limiting pathophysiologic mechanism(s) and/or performance differences, and 3) formulate function-based prognostic stratification. Cardiopulmonary ET certainly carries an additional cost as well as competency requirements and is not an essential component of evaluation in all patient populations. However, there are several conditions of confirmed, suspected, or unknown etiology where the data gained from this form of ET is highly valuable in terms of clinical decision making
No takes yet. Share an insight, caveat, or question.
Guazzi et al. (2012) studied Cardiovascular, pulmonary, and musculoskeletal diseases undergoing cardiopulmonary exercise testing (CPX). Cardiopulmonary exercise testing (CPX) with ventilatory expired gas analysis vs. Standard exercise testing (ET) without ventilatory gas exchange measurement was evaluated on Clinical decision-making, diagnostic stratification, and prognostic assessment (e.g., peak VO2 <10.0 mL O2·kg−1·min−1 and VE/VCO2 slope ≥45 in systolic HF). Cardiopulmonary exercise testing variables provide condition-specific diagnostic and prognostic stratification across cardiovascular and pulmonary diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: